{"url":"https://lda.gov/api/v1/filings/039af6e9-982b-481d-8b7c-a8d9aa203451/","filing_uuid":"039af6e9-982b-481d-8b7c-a8d9aa203451","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/039af6e9-982b-481d-8b7c-a8d9aa203451/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Andrew Quinn","dt_posted":"2025-10-20T15:55:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1625 Eye Street, NW","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":292573,"url":"https://lda.gov/api/v1/registrants/292573/","house_registrant_id":37315,"name":"MCALLISTER & QUINN, LLC","description":"​Federal and Foundation Grants and Government Relations consulting firm.","address_1":"1625 Eye Street, NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDRE JACOBS","contact_telephone":"+1 202-296-2741","dt_updated":"2026-07-28T15:00:16.459053-04:00"},"client":{"id":69188,"url":"https://lda.gov/api/v1/clients/69188/","client_id":69188,"name":"AURAVAX THERAPEUTICS","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9077,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"QUINN","suffix":null,"suffix_display":null},"covered_position":"SA, LA - Rep. Hoyer","new":true},{"lobbyist":{"id":140316,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"FOLEY","suffix":null,"suffix_display":null},"covered_position":"LA - Rep. McCollum","new":true},{"lobbyist":{"id":142037,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"HOIS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9077,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"QUINN","suffix":null,"suffix_display":null},"covered_position":"SA, LA - Rep. Hoyer","new":true},{"lobbyist":{"id":140316,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"FOLEY","suffix":null,"suffix_display":null},"covered_position":"LA - Rep. McCollum","new":true},{"lobbyist":{"id":142037,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"HOIS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142037,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"HOIS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":9077,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"QUINN","suffix":null,"suffix_display":null},"covered_position":"SA, LA - Rep. Hoyer","new":true},{"lobbyist":{"id":140316,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"FOLEY","suffix":null,"suffix_display":null},"covered_position":"LA - Rep. McCollum","new":true}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}